U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06861179) titled 'The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis' on March 02.
Brief Summary: The objectives of this clinical trial were to determine the radioprotective effects and underlying biological mechanisms of Phellinus igniarius and its active components during radiotherapy in patients with thoracic malignant tumors.
The study group was given the formulation of Compound Phellinus igniarius decoction daily during radiotherapy, 150ml bid until the end of radiotherapy; The control group only received standard dose radiotherapy without the formulation of Compound Phellinus igniarius decoction intervention.
T...